Obinutuzumab for Relapsing Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis

Saved in:
Bibliographic Details
Main Authors: Michael Cammarata, Brendan Denvir, Aditi Singh, Bangchen Wang, Brendan Antiochos, Duvuru Geetha
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024925002517
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849330299450687488
author Michael Cammarata
Brendan Denvir
Aditi Singh
Bangchen Wang
Brendan Antiochos
Duvuru Geetha
author_facet Michael Cammarata
Brendan Denvir
Aditi Singh
Bangchen Wang
Brendan Antiochos
Duvuru Geetha
author_sort Michael Cammarata
collection DOAJ
format Article
id doaj-art-6b66b0a2ddbc4ea1a3657c22ad3f2adf
institution Kabale University
issn 2468-0249
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
series Kidney International Reports
spelling doaj-art-6b66b0a2ddbc4ea1a3657c22ad3f2adf2025-08-20T03:46:58ZengElsevierKidney International Reports2468-02492025-06-011062065206810.1016/j.ekir.2025.04.026Obinutuzumab for Relapsing Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody–Associated GlomerulonephritisMichael Cammarata0Brendan Denvir1Aditi Singh2Bangchen Wang3Brendan Antiochos4Duvuru Geetha5Division of Hospital Medicine, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USADivision of Rheumatology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA; Correspondence: Brendan Denvir, Johns Hopkins Medicine, 5200 Eastern Avenue, Baltimore, Maryland 21224, USA.Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USADepartment of Pathology, Johns Hopkins University, Baltimore, Maryland, USADivision of Rheumatology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USADivision of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USAhttp://www.sciencedirect.com/science/article/pii/S2468024925002517
spellingShingle Michael Cammarata
Brendan Denvir
Aditi Singh
Bangchen Wang
Brendan Antiochos
Duvuru Geetha
Obinutuzumab for Relapsing Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis
Kidney International Reports
title Obinutuzumab for Relapsing Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis
title_full Obinutuzumab for Relapsing Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis
title_fullStr Obinutuzumab for Relapsing Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis
title_full_unstemmed Obinutuzumab for Relapsing Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis
title_short Obinutuzumab for Relapsing Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis
title_sort obinutuzumab for relapsing myeloperoxidase antineutrophil cytoplasmic autoantibody associated glomerulonephritis
url http://www.sciencedirect.com/science/article/pii/S2468024925002517
work_keys_str_mv AT michaelcammarata obinutuzumabforrelapsingmyeloperoxidaseantineutrophilcytoplasmicautoantibodyassociatedglomerulonephritis
AT brendandenvir obinutuzumabforrelapsingmyeloperoxidaseantineutrophilcytoplasmicautoantibodyassociatedglomerulonephritis
AT aditisingh obinutuzumabforrelapsingmyeloperoxidaseantineutrophilcytoplasmicautoantibodyassociatedglomerulonephritis
AT bangchenwang obinutuzumabforrelapsingmyeloperoxidaseantineutrophilcytoplasmicautoantibodyassociatedglomerulonephritis
AT brendanantiochos obinutuzumabforrelapsingmyeloperoxidaseantineutrophilcytoplasmicautoantibodyassociatedglomerulonephritis
AT duvurugeetha obinutuzumabforrelapsingmyeloperoxidaseantineutrophilcytoplasmicautoantibodyassociatedglomerulonephritis